C Messiou1, D J Collins, S Giles, J S de Bono, D Bianchini, N M de Souza. 1. Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Surrey, UK. Christina.Messiou@icr.ac.uk
Abstract
OBJECTIVES: To determine whether changes in ADC of bone metastases secondary to prostate carcinoma are significantly different in responders compared with progressors on chemotherapy. METHODS: Twenty-six patients with known bone metastases secondary to prostate carcinoma underwent diffusion-weighted MRI of the lumbar spine and pelvis at baseline and 12 weeks following chemotherapy. RECIST assessment of staging CT and PSA taken at the same time points were used to classify patients as responders, progressors or stable. ADC (from b = 0,50,100,250,500,750 smm⁻²) and ADC(slow) (from b = 100,250,500,750 smm⁻²) were calculated for up to 5 lesions per patient. RESULTS: Mean ADC/ADC(slow) in lesions from responders and progressors showed a significant increase. Although the majority of lesions demonstrated an ADC/ADC(slow) rise, some lesions in both responders and progressors demonstrated a fall in ADC beyond the limits of reproducibility. CONCLUSIONS: Mean ADC is not an appropriate measure of response in bone metastases. The heterogeneity of changes in ADC is likely to be related to the composition of bone marrow with changes that have opposing effects on ADC.
OBJECTIVES: To determine whether changes in ADC of bone metastases secondary to prostate carcinoma are significantly different in responders compared with progressors on chemotherapy. METHODS: Twenty-six patients with known bone metastases secondary to prostate carcinoma underwent diffusion-weighted MRI of the lumbar spine and pelvis at baseline and 12 weeks following chemotherapy. RECIST assessment of staging CT and PSA taken at the same time points were used to classify patients as responders, progressors or stable. ADC (from b = 0,50,100,250,500,750 smm⁻²) and ADC(slow) (from b = 100,250,500,750 smm⁻²) were calculated for up to 5 lesions per patient. RESULTS: Mean ADC/ADC(slow) in lesions from responders and progressors showed a significant increase. Although the majority of lesions demonstrated an ADC/ADC(slow) rise, some lesions in both responders and progressors demonstrated a fall in ADC beyond the limits of reproducibility. CONCLUSIONS: Mean ADC is not an appropriate measure of response in bone metastases. The heterogeneity of changes in ADC is likely to be related to the composition of bone marrow with changes that have opposing effects on ADC.
Authors: G J Bubley; M Carducci; W Dahut; N Dawson; D Daliani; M Eisenberger; W D Figg; B Freidlin; S Halabi; G Hudes; M Hussain; R Kaplan; C Myers; W Oh; D P Petrylak; E Reed; B Roth; O Sartor; H Scher; J Simons; V Sinibaldi; E J Small; M R Smith; D L Trump; G Wilding Journal: J Clin Oncol Date: 1999-11 Impact factor: 44.544
Authors: Carolin Reischauer; Johannes M Froehlich; Dow-Mu Koh; Nicole Graf; Christian Padevit; Hubert John; Christoph A Binkert; Peter Boesiger; Andreas Gutzeit Journal: Radiology Date: 2010-09-09 Impact factor: 11.105
Authors: E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij Journal: Eur J Cancer Date: 2009-01 Impact factor: 9.162
Authors: Kuei C Lee; Sudha Sud; Charles R Meyer; Bradford A Moffat; Thomas L Chenevert; Alnawaz Rehemtulla; Kenneth J Pienta; Brian D Ross Journal: Cancer Res Date: 2007-04-15 Impact factor: 12.701
Authors: Stefan Rozel; Craig J Galbán; Klaas Nicolay; Kuei C Lee; Sudha Sud; Chris Neeley; Linda A Snyder; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross; Kenneth J Pienta Journal: J Cell Biochem Date: 2009-05-01 Impact factor: 4.429
Authors: Kuei C Lee; Deborah A Bradley; Maha Hussain; Charles R Meyer; Thomas L Chenevert; Jon A Jacobson; Timothy D Johnson; Craig J Galban; Alnawaz Rehemtulla; Kenneth J Pienta; Brian D Ross Journal: Neoplasia Date: 2007-12 Impact factor: 5.715
Authors: F E Lecouvet; A Larbi; V Pasoglou; P Omoumi; B Tombal; N Michoux; J Malghem; R Lhommel; B C Vande Berg Journal: Eur Radiol Date: 2013-03-01 Impact factor: 5.315
Authors: Raquel Perez-Lopez; Joaquin Mateo; Helen Mossop; Matthew D Blackledge; David J Collins; Mihaela Rata; Veronica A Morgan; Alison Macdonald; Shahneen Sandhu; David Lorente; Pasquale Rescigno; Zafeiris Zafeiriou; Diletta Bianchini; Nuria Porta; Emma Hall; Martin O Leach; Johann S de Bono; Dow-Mu Koh; Nina Tunariu Journal: Radiology Date: 2016-11-22 Impact factor: 11.105
Authors: Lily H Kim; Edward H Lee; Michelle Galvez; Murat Aksoy; Stefan Skare; Rafael O'Halloran; Michael S B Edwards; Samantha J Holdsworth; Kristen W Yeom Journal: J Neurosurg Spine Date: 2019-07-05